SCHEMBL6387538

SCHEMBL6387538

C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.72

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ NPC1L1 Q9UHC9 6/20 0.70
▸ OSBP P22059 3/20 0.70
▸ OSBP2 Q969R2 3/20 0.70
▸ NR1H3 Q13133 2/20 0.70
▸ RORC P51449 2/20 0.70
▸ CRYAB P02511 1/20 0.70
▸ HMGCR P04035 1/20 0.70
▸ ITGB3 P05106 1/20 0.70
▸ ITGAV P06756 1/20 0.70
▸ SREBF2 Q12772 1/20 0.70
▸ GRIN1 Q05586 4/20 0.64
▸ GRIN2B Q13224 3/20 0.64
▸ GRIN2A Q12879 3/20 0.64
▸ USP2 O75604 1/20 0.55
▸ LMNA P02545 1/20 0.55
▸ ABCB1 P08183 1/20 0.55
▸ CYP46A1 Q9Y6A2 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6393065 1.00 NPC1L1 (0.70) NPC1L1OSBPOSBP2NR1H3RORC
SCHEMBL6392359 0.92 NPC1L1 (0.70) NPC1L1OSBPOSBP2NR1H3RORC
SCHEMBL6392603 0.92 NPC1L1 (0.70) NPC1L1OSBPOSBP2NR1H3RORC
SCHEMBL25333078 0.91 NPC1L1 (0.69) NPC1L1OSBPOSBP2NR1H3RORC
SCHEMBL25333082 0.91 NPC1L1 (0.69) NPC1L1OSBPOSBP2NR1H3RORC
SCHEMBL5341405 0.89 GRIN1 (0.69) NPC1L1OSBPOSBP2NR1H3RORC
SCHEMBL27505687 0.89 OSBP (0.69) NPC1L1OSBPOSBP2NR1H3RORC
SCHEMBL27505688 0.89 OSBP (0.69) NPC1L1OSBPOSBP2NR1H3RORC
SCHEMBL6391751 0.86 OSBP (0.70) NPC1L1OSBPOSBP2NR1H3RORC
SCHEMBL6387282 0.86 OSBP (0.70) NPC1L1OSBPOSBP2NR1H3RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004382-A1 Meiosis regulating compounds GRONDAHL CHRISTIAN (DK) 2005-01-06 — — US disclosed
US-6759400-B2 Meiosis regulating compounds NOVO NORDISK A/S (DK) 2004-07-06 — — US disclosed
EP-0946584-B1 Meiosis regulating compounds NOVO NORDISK AS (DK) 2003-04-23 — — EP disclosed
US-20030032824-A1 Meiosis regulating compounds GRONDAHL CHRISTIAN (DK) 2003-02-13 — — US disclosed
US-6486145-B2 STEROL DERIVATIVE USEFUL IN TREATMENT OF FERTILITY NOVO NORDISK A/S (DK) 2002-11-26 — — US disclosed
EP-0946584-A1 MEIOSIS REGULATING COMPOUNDS NOVO NORDISK A/S (DK) 1999-10-06 — — EP disclosed
WO-1998028323-A1 MEIOSIS REGULATING COMPOUNDS NOVO NORDISK A/S (DK) 1998-07-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030032824-A1 Meiosis regulating compounds MNS1, NR5A1, NASP NPC1L1 2280/4885OSBP 95/4885OSBP2 217/4885
US-20050004382-A1 Meiosis regulating compounds NASP, MNS1, NR5A1 NPC1L1 2324/4885OSBP 95/4885OSBP2 170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback